Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

Completed · Phase 2

Conditions studied: Endometriosis

In brief

The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need for pain medication for endometriosis symptoms; and if the study medication improves a participant's ability to carry out daily activities. Qualified participants will receive no cost treatment, which may include study-related examinations, diagnostic procedures including a Pap smear, laboratory testing, and a mammogram (aged 40-45). Qualified participants will also receive study medication at no cost. As a participant, the study volunteer may also experience the satisfaction of knowing she is helping the advancement of women's health care.

Key facts

Study ID

NCT00110487

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

200

Starts

2005-01-01

Expected to finish

2006-12-01

Last updated by the study team

2015-05-01

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Surgical diagnosis of endometriosis within 5 years
• Not pregnant and not lactating
• Willing to use non-hormonal contraception, history of regular menstrual cycles

You may not qualify if…

• Hysterectomy, surgical treatment for endometriosis within 3 months
• Certain medications for the treatment of endometriosis
• Previous history of a malignancy
• Abnormalities on physical or gyn exams and abnormal lab tests

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Carmichael, California, United States
• Study site — La Jolla, California, United States
• Study site — Redding, California, United States
• Study site — San Diego, California, United States
• Study site — Lakewood, Colorado, United States
• Study site — Aventura, Florida, United States
• Study site — Boynton Beach, Florida, United States
• Study site — Celebration, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Miami, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — Palm Harbor, Florida, United States
• Study site — Alpharetta, Georgia, United States
• Study site — Atlanta, Georgia, United States
• Study site — Arlington Heights, Illinois, United States
• Study site — Champaign, Illinois, United States
• Study site — Chicago, Illinois, United States
• Study site — Chicago, Illinois, United States
• Study site — Oak Brook, Illinois, United States
• Study site — South Bend, Indiana, United States
• Study site — Shreveport, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.